Adjusted significance levels for subgroup analyses in clinical trials
- 30 November 2010
- journal article
- Published by Elsevier BV in Contemporary Clinical Trials
- Vol. 31 (6), 647-656
- https://doi.org/10.1016/j.cct.2010.08.011
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Adaptive patient enrichment designs in therapeutic trialsBiometrical Journal, 2009
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncologyStatistics in Medicine, 2009
- Approaches to evaluation of treatment effect in randomized clinical trials with genomic subsetPharmaceutical Statistics, 2007
- A method for testing a prespecified subgroup in clinical trialsStatistics in Medicine, 2007
- Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive PatientsClinical Cancer Research, 2005
- Evaluation of a weighted multiple comparison procedurePharmaceutical Statistics, 2005
- Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential StudiesJournal of the American Statistical Association, 1997
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon StatisticJournal of the American Statistical Association, 1982
- On closed testing procedures with special reference to ordered analysis of varianceBiometrika, 1976